TCL Archive New benchmark for CCSG award funding will be lowered from 20 percent of NCI research base to 15 percent, the program’s “reality ratio,” Karen Antman tells NCAB. October 8, 2004
TCL Archive Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say July 24, 2009
